64 related articles for article (PubMed ID: 20064366)
1. Integrins and mutant p53 on the road to metastasis.
Selivanova G; Ivaska J
Cell; 2009 Dec; 139(7):1220-2. PubMed ID: 20064366
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 drives invasion by promoting integrin recycling.
Muller PA; Caswell PT; Doyle B; Iwanicki MP; Tan EH; Karim S; Lukashchuk N; Gillespie DA; Ludwig RL; Gosselin P; Cromer A; Brugge JS; Sansom OJ; Norman JC; Vousden KH
Cell; 2009 Dec; 139(7):1327-41. PubMed ID: 20064378
[TBL] [Abstract][Full Text] [Related]
3. A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis.
Adorno M; Cordenonsi M; Montagner M; Dupont S; Wong C; Hann B; Solari A; Bobisse S; Rondina MB; Guzzardo V; Parenti AR; Rosato A; Bicciato S; Balmain A; Piccolo S
Cell; 2009 Apr; 137(1):87-98. PubMed ID: 19345189
[TBL] [Abstract][Full Text] [Related]
4. Regulation of metastasis-related gene expression by p53: a potential clinical implication.
Sun Y; Wicha M; Leopold WR
Mol Carcinog; 1999 Jan; 24(1):25-8. PubMed ID: 10029407
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
6. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
[TBL] [Abstract][Full Text] [Related]
7. beta-tting on p63 as a metastatic suppressor.
Clohessy JG; Pandolfi PP
Cell; 2009 Apr; 137(1):28-30. PubMed ID: 19345184
[TBL] [Abstract][Full Text] [Related]
8. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitors: motivators of metastasis?
Steeg PS
Nat Med; 2003 Jul; 9(7):822-3. PubMed ID: 12835693
[No Abstract] [Full Text] [Related]
10. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
11. Integrin modulating factor: a 30-kD protein that modulates the expression and function of alpha5beta1 integrin receptor.
Ray S; Chattopadhyay N; Sanyal U; Biswas N; Chatterjee A
J Environ Pathol Toxicol Oncol; 2001; 20(3):199-209. PubMed ID: 11797829
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
13. Lebectin and lebecetin, two C-type lectins from snake venom, inhibit alpha5beta1 and alphaV-containing integrins.
Sarray S; Delamarre E; Marvaldi J; El Ayeb M; Marrakchi N; Luis J
Matrix Biol; 2007 May; 26(4):306-13. PubMed ID: 17300927
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
[TBL] [Abstract][Full Text] [Related]
16. p53 Attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts.
Moskovits N; Kalinkovich A; Bar J; Lapidot T; Oren M
Cancer Res; 2006 Nov; 66(22):10671-6. PubMed ID: 17108103
[TBL] [Abstract][Full Text] [Related]
17. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
Lössner D; Abou-Ajram C; Benge A; Reuning U
Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
[TBL] [Abstract][Full Text] [Related]
18. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
20. Colon cancer cells adhesion and spreading on autocrine laminin-10 is mediated by multiple integrin receptors and modulated by EGF receptor stimulation.
Pouliot N; Connolly LM; Moritz RL; Simpson RJ; Burgess AW
Exp Cell Res; 2000 Dec; 261(2):360-71. PubMed ID: 11112342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
